700 related articles for article (PubMed ID: 32882269)
21. Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies.
Hasanzadeh A; Alamdaran M; Ahmadi S; Nourizadeh H; Bagherzadeh MA; Mofazzal Jahromi MA; Simon P; Karimi M; Hamblin MR
J Control Release; 2021 Aug; 336():354-374. PubMed ID: 34175366
[TBL] [Abstract][Full Text] [Related]
22. Nanotechnology-based antiviral therapeutics.
Chakravarty M; Vora A
Drug Deliv Transl Res; 2021 Jun; 11(3):748-787. PubMed ID: 32748035
[TBL] [Abstract][Full Text] [Related]
23. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
[TBL] [Abstract][Full Text] [Related]
24. Development and application of a SARS-CoV-2 colorimetric biosensor based on the peroxidase-mimic activity of γ-Fe
Büyüksünetçi YT; Çitil BE; Tapan U; Anık Ü
Mikrochim Acta; 2021 Sep; 188(10):335. PubMed ID: 34505191
[TBL] [Abstract][Full Text] [Related]
25. COVID-19: Progress in diagnostics, therapy and vaccination.
Liu X; Liu C; Liu G; Luo W; Xia N
Theranostics; 2020; 10(17):7821-7835. PubMed ID: 32685022
[TBL] [Abstract][Full Text] [Related]
26. COVID-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods.
Marofi F; Azizi R; Motavalli R; Vahedi G; Nasimi M; Yousefi M; Motavalli Y; Tahmasebi S; Gharibi T; Mohammed RN; Etemadi J; Khiavi FM
Anticancer Agents Med Chem; 2021 Oct; 21(16):2142-2162. PubMed ID: 33563186
[TBL] [Abstract][Full Text] [Related]
27. Engineered two-dimensional nanomaterials based diagnostics integrated with internet of medical things (IoMT) for COVID-19.
Sadique MA; Yadav S; Khan R; Srivastava AK
Chem Soc Rev; 2024 Apr; 53(8):3774-3828. PubMed ID: 38433614
[TBL] [Abstract][Full Text] [Related]
28. Application of Nanotechnology in the COVID-19 Pandemic.
Yang D
Int J Nanomedicine; 2021; 16():623-649. PubMed ID: 33531805
[TBL] [Abstract][Full Text] [Related]
29. Human respiratory viral infections: Current status and future prospects of nanotechnology-based approaches for prophylaxis and treatment.
Dawre S; Maru S
Life Sci; 2021 Aug; 278():119561. PubMed ID: 33915132
[TBL] [Abstract][Full Text] [Related]
30. Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): diagnosis, treatment, therapy and future perspectives.
Rashidzadeh H; Danafar H; Rahimi H; Mozafari F; Salehiabar M; Rahmati MA; Rahamooz-Haghighi S; Mousazadeh N; Mohammadi A; Ertas YN; Ramazani A; Huseynova I; Khalilov R; Davaran S; Webster TJ; Kavetskyy T; Eftekhari A; Nosrati H; Mirsaeidi M
Nanomedicine (Lond); 2021 Mar; 16(6):497-516. PubMed ID: 33683164
[TBL] [Abstract][Full Text] [Related]
31. Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization.
Chiba S; Frey SJ; Halfmann PJ; Kuroda M; Maemura T; Yang JE; Wright ER; Kawaoka Y; Kane RS
Commun Biol; 2021 May; 4(1):597. PubMed ID: 34011948
[TBL] [Abstract][Full Text] [Related]
32. Nanobiosensors as new diagnostic tools for SARS, MERS and COVID-19: from past to perspectives.
Antiochia R
Mikrochim Acta; 2020 Nov; 187(12):639. PubMed ID: 33151419
[TBL] [Abstract][Full Text] [Related]
33. Aptamers as promising nanotheranostic tools in the COVID-19 pandemic era.
Dzuvor CKO; Tettey EL; Danquah MK
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 May; 14(3):e1785. PubMed ID: 35238490
[TBL] [Abstract][Full Text] [Related]
34. An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19.
Yasamineh S; Kalajahi HG; Yasamineh P; Yazdani Y; Gholizadeh O; Tabatabaie R; Afkhami H; Davodabadi F; Farkhad AK; Pahlevan D; Firouzi-Amandi A; Nejati-Koshki K; Dadashpour M
J Nanobiotechnology; 2022 Oct; 20(1):440. PubMed ID: 36209089
[TBL] [Abstract][Full Text] [Related]
35. COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic.
Bhavana V; Thakor P; Singh SB; Mehra NK
Life Sci; 2020 Nov; 261():118336. PubMed ID: 32846164
[TBL] [Abstract][Full Text] [Related]
36. COVID-19 Infection: Targeting Possibilities for Treatment.
Haider T; Gour V; Pandey V; Kanwar IL; Tiwari R; Vishwakarma M; Bakshi AK; Sarkar A; Yadav R; Soni S; Soni V
Crit Rev Ther Drug Carrier Syst; 2021; 38(3):75-115. PubMed ID: 34348019
[TBL] [Abstract][Full Text] [Related]
37. Application of nanomaterials in treatment, anti-infection and detection of coronaviruses.
Nikaeen G; Abbaszadeh S; Yousefinejad S
Nanomedicine (Lond); 2020 Jun; 15(15):1501-1512. PubMed ID: 32378459
[TBL] [Abstract][Full Text] [Related]
38. Carbon dots for virus detection and therapy.
Belza J; Opletalová A; Poláková K
Mikrochim Acta; 2021 Nov; 188(12):430. PubMed ID: 34822008
[TBL] [Abstract][Full Text] [Related]
39. An electrochemical SARS-CoV-2 biosensor inspired by glucose test strip manufacturing processes.
Vezza VJ; Butterworth A; Lasserre P; Blair EO; MacDonald A; Hannah S; Rinaldi C; Hoskisson PA; Ward AC; Longmuir A; Setford S; Farmer ECW; Murphy ME; Corrigan DK
Chem Commun (Camb); 2021 Apr; 57(30):3704-3707. PubMed ID: 33729260
[TBL] [Abstract][Full Text] [Related]
40. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
Hosoki K; Chakraborty A; Sur S
J Allergy Clin Immunol; 2020 Aug; 146(2):285-299. PubMed ID: 32624257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
